Details
Stereochemistry | ACHIRAL |
Molecular Formula | C12H10O4 |
Molecular Weight | 218.2054 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 2 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)\C=C\C=C\C1=CC=C2OCOC2=C1
InChI
InChIKey=RHBGITBPARBDPH-ZPUQHVIOSA-N
InChI=1S/C12H10O4/c13-12(14)4-2-1-3-9-5-6-10-11(7-9)16-8-15-10/h1-7H,8H2,(H,13,14)/b3-1+,4-2+
Molecular Formula | C12H10O4 |
Molecular Weight | 218.2054 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 2 |
Optical Activity | NONE |
Piperic Acid is a metabolite of Piperine. Piperic acid is found in herbs and spices. Piperic acid is obtained from black pepper (Piper nigrum), from Minthostachys verticillata, peppermint (Mentha piperita) and others. Piperic acid is an intermediate in the synthesis of other compounds such as piperonal, and as-such may be used to produce fragrances, perfumes flavorants and drugs as well as other useful compounds. The cytotoxic effects of piperic acid in prostate cancer cells (PC-3) and breast cancer cells (MDA-MB-231) were studied. The drug treatment experiments clearly indicated that maximum cytotoxicity was achieved at 48 hours and at 100uM concentration of piperic acid in both the cell lines. It is proposed that piperine might get metabolized into piperonylic acid, piperic acid, and piperonal in human as evidenced in rats. Hence, the three derivatives of piperine presented above shall be of therapeutic significance. Piperic Acid has revealed Lipoxygenase (LOX) inhibitory activity. The possibility of exploiting the higher LOX inhibitory activity and lower IC50 values of piperine
derivatives, piperonal, and piperonylic acid, in various ways for therapeutic applications, especially with fermented herbal drugs containing materials with piperine as a constituent has being suggested.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL390 |
|||
Target ID: CHEMBL4586 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25327968 |
45.17 µM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 00:14:02 GMT 2023
by
admin
on
Sat Dec 16 00:14:02 GMT 2023
|
Record UNII |
GFG3FLA9UR
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
129538
Created by
admin on Sat Dec 16 00:14:02 GMT 2023 , Edited by admin on Sat Dec 16 00:14:02 GMT 2023
|
PRIMARY | |||
|
GFG3FLA9UR
Created by
admin on Sat Dec 16 00:14:02 GMT 2023 , Edited by admin on Sat Dec 16 00:14:02 GMT 2023
|
PRIMARY | |||
|
m8849
Created by
admin on Sat Dec 16 00:14:02 GMT 2023 , Edited by admin on Sat Dec 16 00:14:02 GMT 2023
|
PRIMARY | Merck Index | ||
|
226-118-4
Created by
admin on Sat Dec 16 00:14:02 GMT 2023 , Edited by admin on Sat Dec 16 00:14:02 GMT 2023
|
PRIMARY | |||
|
5370536
Created by
admin on Sat Dec 16 00:14:02 GMT 2023 , Edited by admin on Sat Dec 16 00:14:02 GMT 2023
|
PRIMARY | |||
|
PIPERIC ACID
Created by
admin on Sat Dec 16 00:14:02 GMT 2023 , Edited by admin on Sat Dec 16 00:14:02 GMT 2023
|
PRIMARY | |||
|
DTXSID40871913
Created by
admin on Sat Dec 16 00:14:02 GMT 2023 , Edited by admin on Sat Dec 16 00:14:02 GMT 2023
|
PRIMARY | |||
|
5285-18-7
Created by
admin on Sat Dec 16 00:14:02 GMT 2023 , Edited by admin on Sat Dec 16 00:14:02 GMT 2023
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
37316
Created by
admin on Sat Dec 16 00:14:02 GMT 2023 , Edited by admin on Sat Dec 16 00:14:02 GMT 2023
|
PRIMARY | |||
|
136-72-1
Created by
admin on Sat Dec 16 00:14:02 GMT 2023 , Edited by admin on Sat Dec 16 00:14:02 GMT 2023
|
PRIMARY |